A billion-dollar exit

In the biggest deal ever for an Israeli medical device company, US-based HeartWare International is acquiring Israeli biotech start-up Valtech Cardio. Valtech shareholders will receive HeartWare stock worth over $900 million, depending on milestones. Valtech makes heart valve surgery devices.


This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *